CRISPR vs Gene Therapy for Sickle Cell: Which Treatment Works Better? Introduction Sickle cell disease (SCD) remains one of the most prevalent inherited hematologic disorders globally, affecting millions of individuals across diverse populations. It is estimated that approximately 100,000 people in the United States live
Tag: CRISPR-Cas9–based therapy
